Navigation Links
Black Breast Cancer Survivors Face Higher Heart Failure Risk: Study
Date:3/7/2013

THURSDAY, March 7 (HealthDay News) -- Black breast cancer survivors seem more likely to develop heart failure than other women, a new study says.

Researchers analyzed data from more than 26,000 U.S. women who were diagnosed with breast cancer between 1973 and 2007 and survived. More than three-quarters were 65 or older.

Of these women, 16 percent later developed heart failure. The rate of heart failure was 21 percent among black women, 16 percent among whites, 13 percent among Hispanics, 12 percent among Asians and 11 percent among others, including Native Americans.

Heart failure occurs when the heart can no longer pump enough blood to the rest of the body. About half of people with heart failure die within five years after diagnosis, according to the U.S. Centers for Disease Control and Prevention.

According to the study, black breast cancer survivors had a 1.4-fold greater risk of heart failure than white survivors, although both had the same risk of dying after developing heart failure. The study is scheduled for presentation Thursday at the American College of Cardiology's annual scientific meeting in San Francisco.

The increased risk among black women remained even after the researchers accounted for other factors, including age, high blood pressure, diabetes and the use of chemotherapy drugs or medicines to protect the heart -- called cardioprotective drugs.

The findings could prove important for the nearly 27,000 new cases of breast cancer diagnosed in black women each year, the researchers said.

"In general, African-American women are more susceptible to heart problems as they are disproportionately affected by high blood pressure, obesity, diabetes, high oxidative stress and even vitamin D deficiency," study lead investigator Dr. Anna Valina-Toth, a second-year internal medicine resident at Case Western Reserve University, in Cleveland, said in a university news release. "Our findings suggest that these women may require closer monitoring to detect the risk of heart failure earlier."

The researchers said their study is the first to reveal how often heart failure occurs in a large, representative sample of U.S. breast cancer survivors.

Breast cancer survivors are at increased risk for heart failure due to the use of anthracycline and trastuzumab, two of the most effective chemotherapy treatments. These drugs can damage the heart, depending on the amount a patient receives during treatment. Cardioprotective drugs might help prevent this damage, and their effectiveness should be studied, Valina-Toth said.

While the study uncovered a link involving race, breast cancer and heart failure, it didn't prove the existence of a cause-and-effect relationship. Findings presented at medical meetings are considered preliminary until published in a peer-reviewed medical journal.

More information

The U.S. National Heart, Lung, and Blood Institute has more about heart failure.

-- Robert Preidt

SOURCE: American College of Cardiology, news release, March 7, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pending Upheaval in"The Year of the Great EHR Switch" Shifts Spotlight to e-Health Industry's Best, Black Book Reveals 2013 Top Scoring Vendors
2. Obama MIA On Jim Crow During Black History Month
3. A Few Extra Pounds May Harm Lung Function in Black, Hispanic Kids
4. 2013 Top Black Book Electronic Health Records (EHR) Systems Announced for Ambulatory Physician Groups
5. Top Hospital Electronic Health Records Vendors Rated by Client Satisfaction, Black Book Rankings Announce 2013 Inpatient EHR Leaders
6. Electronic Health Record sellers face make-or-break year of client ultimatums and revolts, reveals 2013 Black Book survey
7. Obese Black Women at Higher Risk for Having Very Large Babies
8. Obesity coverage in black newspapers is mostly negative, MU study finds
9. Breast-Feeding Still Less Common for Black Babies: CDC
10. Cancer Rates Dropping Among Black Americans
11. Blackall Mechanical, Inc. Expands Project Department to Better Serve Customers in North and South Texas
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Black Breast Cancer Survivors Face Higher Heart Failure Risk: Study
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: